Opko Health (OPK -7.42%), a diversified healthcare company operating in diagnostics and pharmaceuticals, released its second quarter 2025 results on July 31, 2025. The company reported a significant revenue miss, with total GAAP revenue at $156.8 million, compared to analyst expectations of$165.7 million for Q2 2025. Its net loss per share on a GAAP basis reached $0.19, wider than estimates for a$0.11 loss and sharply higher than the prior-year figure in Q2 2025. Results were affected by lower diagnostics ...